Padcev, a drug Pfizer acquired in 2023, is a part of the only chemo-free treatment for bladder cancer patients newly ...
Health disparities in marginalized communities are rooted in systemic factors such as discrimination and unequal access to ...
Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...
It's been nearly five years since the pandemic started, but COVID-19 doesn't take a break over the holidays. From shopping to ...
The world’s largest pharmaceutical company by 2023 revenue, Pfizer Inc. (PFE) is down more than 13% year-to-date, while the ...
The power of owning dividend-paying stocks is often underappreciated. Consider, for example, that a study by Hartford Funds ...
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
California-based BridgeBio has secured US FDA approval for its lead candidate drug, acoramidis (brand name Attruby) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback